Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia

Emily K. Robinson, Christine M. Seaworth, James W. Suliburk, Sasha D. Adams, Lillian S. Kao, David W Mercer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Methods - Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n ≥ 4/group; ANOVA). Results - Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Conclusions - Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.

Original languageEnglish (US)
Pages (from-to)507-514
Number of pages8
JournalShock
Volume25
Issue number5
DOIs
StatePublished - May 1 2006

Fingerprint

Endotoxemia
Matrix Metalloproteinases
Stomach
Matrix Metalloproteinase 2
Matrix Metalloproteinase 14
NG-Nitroarginine Methyl Ester
Tissue Inhibitor of Metalloproteinase-2
Wounds and Injuries
Membrane-Associated Matrix Metalloproteinases
Tissue Inhibitor of Metalloproteinases
Proteins
Matrix Metalloproteinase Inhibitors
Gelatin
Extracellular Matrix
Sprague Dawley Rats
Analysis of Variance

Keywords

  • Aminoguanadine
  • Gelatinase
  • Injury
  • Lipopolysaccharide
  • MT1-MMP
  • N -nitro-L-arginine methyl ester
  • NO
  • TIMP

ASJC Scopus subject areas

  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia. / Robinson, Emily K.; Seaworth, Christine M.; Suliburk, James W.; Adams, Sasha D.; Kao, Lillian S.; Mercer, David W.

In: Shock, Vol. 25, No. 5, 01.05.2006, p. 507-514.

Research output: Contribution to journalArticle

Robinson, Emily K. ; Seaworth, Christine M. ; Suliburk, James W. ; Adams, Sasha D. ; Kao, Lillian S. ; Mercer, David W. / Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia. In: Shock. 2006 ; Vol. 25, No. 5. pp. 507-514.
@article{90715963161b4e99b0661b3796ae64cb,
title = "Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia",
abstract = "Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Methods - Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n ≥ 4/group; ANOVA). Results - Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Conclusions - Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.",
keywords = "Aminoguanadine, Gelatinase, Injury, Lipopolysaccharide, MT1-MMP, N -nitro-L-arginine methyl ester, NO, TIMP",
author = "Robinson, {Emily K.} and Seaworth, {Christine M.} and Suliburk, {James W.} and Adams, {Sasha D.} and Kao, {Lillian S.} and Mercer, {David W}",
year = "2006",
month = "5",
day = "1",
doi = "10.1097/01.shk.0000209543.83929.bd",
language = "English (US)",
volume = "25",
pages = "507--514",
journal = "Shock (Augusta, Ga.)",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia

AU - Robinson, Emily K.

AU - Seaworth, Christine M.

AU - Suliburk, James W.

AU - Adams, Sasha D.

AU - Kao, Lillian S.

AU - Mercer, David W

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Methods - Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n ≥ 4/group; ANOVA). Results - Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Conclusions - Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.

AB - Matrix metalloproteinases (MMPs) degrade the extracellular matrix and contribute to LPS-induced gastric injury. MMPs are closely modulated by their activators, membrane type-MMP (MT-MMPs) and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). As LPS-induced gastric injury is mediated in part by iNOS, and NO modulates MMP production in vitro, we hypothesized that NOS inhibition would similarly modulate LPS-induced gastric MMP production. Therefore, the purpose of these studies was to compare the effects of selective and nonselective NOS inhibition on LPS-induced gastric MMP production. Methods - Sprague-Dawley rats were given either the nonselective NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 5 mg/kg, s.c.), a selective iNOS inhibitor, aminoguanidine (45 mg/kg, i.p.) or L-N-iminoethyl-lysine (L-NIL; 10 mg/kg, i.p.), or vehicle 15 min before saline or LPS (20 mg/kg, i.p.) and killed 24 h after LPS administration. Stomachs were assessed for macroscopic injury (computed planimetry), and gastric mucosal MMP production was assessed by gelatin zymography, in situ zymography, and Western analysis for MMP-2, MT1-MMP, and TIMP-2. (n ≥ 4/group; ANOVA). Results - Aminoguanidine treatment decreased LPS-induced macroscopic gastric injury as well as MMP-2 and MT1-MMP protein production while having no effect on TIMP-2 protein levels. L-NIL similarly attenuated the induction of MMP-2 and MT1-MMP by LPS. L-NAME failed to attenuate LPS induced gastric injury or MT1-MMP protein induction and increased MMP-2 levels. L-NAME similarly had no effect on gastric TIMP-2 production. Conclusions - Selective iNOS inhibition decreases gastric MMP-2 activity after LPS administration, whereas nonselective inhibition increases MMP-2 levels. The ability of selective iNOS inhibition to ameliorate LPS-induced gastric injury may be due in part to its inhibition of active MMP-2 production, whereas nonselective NOS inhibitors increase MMP-2 levels and maintain gastric injury after LPS administration.

KW - Aminoguanadine

KW - Gelatinase

KW - Injury

KW - Lipopolysaccharide

KW - MT1-MMP

KW - N -nitro-L-arginine methyl ester

KW - NO

KW - TIMP

UR - http://www.scopus.com/inward/record.url?scp=33646819044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646819044&partnerID=8YFLogxK

U2 - 10.1097/01.shk.0000209543.83929.bd

DO - 10.1097/01.shk.0000209543.83929.bd

M3 - Article

VL - 25

SP - 507

EP - 514

JO - Shock (Augusta, Ga.)

JF - Shock (Augusta, Ga.)

SN - 1073-2322

IS - 5

ER -